|
QNCX Quince Therapeutics Inc 1662774 |
| Balance Sheet |
|
Current Assets
|
51,718,000 |
|
Assets
|
126,519,000 |
|
Current Liabilities
|
5,425,000 |
|
Liabilities
|
81,587,000 |
|
Equity
|
44,932,000 |
|
Shares Out
|
43,277,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-24,352,000 |
|
Investing Cash Flow
|
11,041,000 |
| Market Analysis |
Market Cap
|
32,001,736 |
|
Price
|
1.37 |
|
BVPS
|
1.04 |
|
PB
|
1.32 |
|
EPS
|
-1.27 |
|
PS
|
1.26 |
|
FCF
|
-13,311,000 |
|
| Earnings |
|
| Apr |
May |
Jun |
| 4/01 |
|
5/13 |
-0.26 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view QNCX documents filed with the SEC.
QNCX Filings
Clear
